A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. [electronic resource]
Producer: 20100823Description: 192-8 p. digitalISSN:- 1933-0693
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Agents, Alkylating -- therapeutic use
- Brain Neoplasms -- drug therapy
- Combined Modality Therapy
- Dacarbazine -- analogs & derivatives
- ErbB Receptors -- immunology
- Female
- Glioblastoma -- drug therapy
- Humans
- Iodine Radioisotopes -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Proportional Hazards Models
- Prospective Studies
- Radioimmunotherapy -- adverse effects
- Radiotherapy, Adjuvant -- adverse effects
- Temozolomide
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.